--- the subscriber area has no ads and those above are not selected or endorsed by this site ---


eMagin dilution -5


eMagin has filed to raise $10M through the sale of shares and warrants, just as I feared with the last report.  There are no details yet, but selling warrants is particularly troubling.  Even without them, this would almost certainly represent almost 20% dilution.  If the terms of the placement aren't good, EMAN shareholders could very well be at risk of a dreaded reverse split to avoid delisting, and then further value erosion from there.